‘Switching off’ enzyme prevents diet-induced obesity, other metabolic diseases

An international team led by Monash University and Baylor College of Medicine, Texas, has found “switching off” an enzyme called CaMKK2 in immune cells that drive inflammation prevents diet-induced obesity, diabetes and fatty liver disease.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup